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Abstract 
A high molecular weight protein fraction (PI) from rat brain that exhibited heat- and acid-resistant properties like ferritin was 
characterized with respect o its reactivity with spleen ferritin antiserum, iron (Fe) content and Fe and aluminum (A1) binding. This 
fraction eluted on Sepharose 4.B and Sepharose 6B columns with an apparent Mr of 2 100 000. A second Fe-rich fraction (PII) with an M r 
of 500 000 showed lower anti-ferritin activity. The PI and PII fractions from liver, when prepared without he heat and acid steps, were 
similar to those found in brain. In both tissues, the PI fraction had a low Fe/ferritin ratio (0.28 + 0.08 /xg//zg for brain and 0.22 + 0.05 
/zg/gg for liver). Similarly the PII fractions had high Fe/ferritin ratios (1.48 + 0.44/xg//xg for brain and 1.34 + 0.10/zg//xg for liver). 
Analysis of Fe binding to brain PI revealed one high affinity site (K d = 157 + 30.0 X 10 -6  M; Bma x = 1.42 +_ 0.11 /xmol Fe/mg 
protein) and one low affinity site (K  d = 890 +_ 100 X l0  -6  M;  Bma x = 5.24 + 0.96 /zmol Fe/mg protein). Removal of Fe from brain PI 
with 1% thioglycollic acid solution prior to Fe binding, increased binding affinity at both sites, while total binding remained unchanged. 
Al bound to brain PI with high affinity (K d = 59.7 __ 13.6 × l 0  -6  M; Bma x = 0.24 _+ 0.02 /xmol A1/mg protein). These results 
demonstrate he presence of two ferritin-like, metal-binding (MB) proteins in rat brain. 
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1. Introduction 
Ferritin is the main iron (Fe) storage protein in verte- 
brates and invertebrates [1], and may also provide cellular 
detoxification through the binding of Fe and other poten- 
tially toxic metals [2-4]. ]vlammalian ferritins consist of a 
protein shell with 24 subunits, each subunit weighing 
either 19,766 Da (the L subunit) or 21,099 Da (the H 
subunit) [5], surrounding a core of ferrihydrite [1]. Ferritin 
Fe content ranges from 0 to 4500 atoms/molecule. Even 
though most ferritins weigh less than 500 000 Da, ferritins 
containing 34-38 subunits [6] and ferritins weighing up to 
1 100000 Da have also been reported [7]. Ferritins of even 
higher molecular weight may account for up to a consider- 
able proportion of ferritin prepared from various tissues. 
These ferritins are non-covalently bound dimers, tfimers, 
and higher oligomers of individual ferritin monomers [8,9]. 
Brain ferritin has been reported to have a 60-70% H 
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subunit content while horse spleen ferritin (HSF) and 
mammalian liver ferritin are predominantly L subunits; 
brain ferritin has been reported to have an Fe saturation of 
1500 atoms/ferritin molecule, half that of liver or spleen 
ferritin [ 10,11]. Since high levels of toxic metals may enter 
the brain, for example, in infants before the blood-brain 
barrier is fully developed, brain ferritin may play an 
important protective role against metal toxicity. It was 
previously shown that ferritin mRNA translatability in 
vitro increased when infant rats, but not infant rabbits, 
were exposed to aluminum (A1) [12]. Increased synthesis 
of ferritin, and of other A1 binding proteins may account 
for the cytoplasmic accumulation of A1 in rats. In rabbits, 
where A1 accumulates in the nucleus, the formation of 10 
nm filaments and encephalopathy [13] have been reported, 
as well as decreased protein synthesis [14,15]. During the 
preparation of brain ferritin, we identified a fraction resis- 
tant to heat and pH denaturation that was present at high 
concentration i the final preparation. This fraction eluted 
on gel filtration chromatography with an apparent molecu- 
lar weight four times that previously reported for ferritin. 
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The present study shows that this fraction cross-reacts with 
antiserum to horse spleen ferritin (HSF), binds both Fe and 
AI, and is not a denatured form of ferritin. These results 
point to the presence of a heavy, metal-binding (MB) 
protein in rat brain, which can be distinguished from the 
500 000 Da brain ferritin. 
elution was monitored by measuring the Fe content of 
fractions at 420 nm [17]. Fractions with the highest ab- 
sorbancy were pooled, concentrated by ultrafiltration (Di- 
aflo ultrafilter PM30, Amicon), and re-eluted on Sepharose 
6B. 
2.3. Preparation of peak I (PI) and peak I1 (PII) fractions 
2. Materials and methods 
2.1. Animals and chemicals 
Wistar rats (5 weeks old at time of sacrifice) were 
obtained from Charles River Canada, St. Constant, Que- 
bec. Rabbit anti-(horse spleen) ferritin delipidized whole 
serum, chromatography standards (blue dextran, thyro- 
globulin, horse spleen apo-ferritin, and catalase), Sephacryi 
S-300, Sepharose 6B and 4B, RNase A (5800 units/ml), 
sodium dodecyl sulphate (SDS) and phenylmethylsulfonyl 
fluoride (PMSF) were from Sigma Chemicals, St. Louis, 
MO. [125I]Anti-ferritin antibody (1.35 /~Ci/ml), was from 
Inter Medico, Markham, ON. Tris-barbiturate buffer con- 
taining 32.1%(w/w) Tris, 13.7%(w/w) Barbital, and 
54.2%(w/w) N'-barbital (pH 8.0) was from Gelman Sci- 
ences, Ann Arbor, MI. Horse spleen ferritin (2 X crystal- 
lized) was from ICN Biomedicals Canada, St-Laurent, 
Que. 
The post-mitochondrial supernatant fraction (S15) was 
obtained from brain homogenate prepared in 0.1 M Tris- 
HCI (pH 7.4) containing 0.1 mg/ml PMSF, by centrifuga- 
tion at 15000Xg for 20 min at 5°C. From this S15 
fraction, the post-microsomal supernatant fraction (S105) 
was prepared by centrifugation at50 000 X g for 60 min at 
5°C. Ferritin and heavier proteins present in the S105 
supernatant fraction, were sedimented by centrifugation at
160000 X g for 3.5 h. The pellet was washed with fresh 
Tris/PMSF buffer, allowed to stand overnight in 1.5 ml of 
Na2HPO 4 buffer (pH 7.0), then resuspended in this buffer, 
and twice centrifuged (two min each) in a bench top 
microfuge to sediment remaining particulate matter. The 
supernatant was finally applied to a Sepharose 6B column. 
Equilibration and elution were with the same buffer. Elu- 
tion of PI and PII ferritin-like proteins was monitored by 
measuring absorbancy at 420 nm. 
2.4. Immunoassay for ferritin epitopes 
2.2. Preparation of t&sue ferritins 
Brain and liver ferritins were prepared by the method of 
Fleming and Joshi [11]. The brains (excluding cerebellum) 
were rinsed with ice-cold 0.9%(w/v) phosphate-buffered 
saline and blotted dry. The tissue (approx. 6 g) was 
homogenized in 2 Vols. of ice-cold 0.1 M Tris-HC1 buffer 
(pH 7.4) containing 0.1 mg/ml PMSF, with 8 strokes of a 
teflon pestle. The solution was first filtered through 3-4 
layers of cheese cloth and then was centrifuged at 70000 
X g for 30 min, at 4°C. The supernatant was decanted, 
heated at 80°C for one minute, and then cooled on ice for 
30 min. Denatured proteins, but not ferritin which is 
heat-resistant [16], were sedimented by centrifugation at 
27000 X g for 10 rain. The supernatant was titrated to pH 
4.8 with dilute acetic acid solution, and maintained at 4°C 
for 60 min, to allow precipitation of proteins insoluble at 
this pH. These proteins were sedimented by centrifugation 
at 20000 × g for 10 min. The supematant, containing 
ferritin, was brought o 50% saturation with solid ammo- 
nium sulfate (protein purification grade), maintained at 4°C 
for 60 min and then centrifuged at 24 000 × g for 20 min. 
The pellet was dissolved in 1 ml of 20 mM Na2HPO 4 
buffer (pH 7.0) containing 0.05% sodium azide and ap- 
plied to a Sephacryl S-300 or Sepharose 6B column. The 
column was equilibrated, and eluted with the same phos- 
phate buffer. One-ml fractions were collected and ferritin 
Samples containing PI or PII proteins were diluted to 
0.5 ml with Tris-barbiturate buffer (pH 8.0) and incubated 
overnight, at 4°C with 60 ~g of ferritin antiserum protein 
containing 0.12 p~Ci of [125I]ferritin antiserum. Immune 
complexes were sedimented by centrifugation at 24 000 X g 
for 15 min, resuspended in 200 /xl Tris-barbiturate buffer, 
then carefully layered over a 200 p.1 'cushion' of 1.0 M 
sucrose in Tris-barbiturate buffer and centrifuged at 24 000 
X g for 15 min. The supernatant was discarded and the 
pellets were counted for radioactivity in a gamma counter 
(Pharmacia-Wallac 1282 CompuGamma CS), at 84% effi- 
ciency. Calibration curves constructed using HSF were 
linear in the range used for the assay (0.25-1.25 /xg of 
ferritin per tube). Values were corrected by subtracting 
values for blank tubes that did not contain PI or PII 
proteins. 
In experiments where PI proteins were eluted in solu- 
tions containing 0.1%(w/v) SDS, column fractions were 
dialysed overnight against 500 Vols. of 20 mM Na2HPO 4 
buffer (pH 7.0) prior to the immunoassay. 
2.5. Fe and Al binding to brain PI and Pll fractions 
Fe and A1 binding to brain PI and PII protein fractions 
was studied by equilibrium dialysis in 6.0 ml, capped 
polypropylene vials. The 0.4 ml aliquots of PI or PII 
proteins (final conc. 0.14 and 0.18 mg/ml, respectively) 
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were placed inside Spectra Por 4 dialysis tubing, prepared 
as described by Pohl [18], and dialysed for at least 16 h at 
4°C, against 0.2 M sodium acetate buffer (pH 6.0) contain- 
ing various concentrations of Fe as ferrous ammonium 
sulfate [19], or A1 citrate [:20,21] in a total volume of 5.0 
ml. Following dialysis, the volume of solution inside the 
bags was carefully measured and aliquots were used for 
metal analyses. This dialysis procedure resulted in com- 
plete equilibration of metals on either side of the mem- 
brane, as determined by metal analysis of protein-free 
blanks. Incubation beyond 16 h did not result in further AI 
binding. 
2.6. Fe determination by atomic absorption spectrometry 
Tissue homogenates, and PI or PII fractions (0.3-2.0 
ml) were digested at 110°C with 2 Vols. of 15.8 N nitric 
acid, as described by Riederer et al. [22]. The dry residue 
was taken up in 1.5 ml of 0.1 N HCI and total Fe was 
determined at 248.3 nm, with a Varian Techtron 1200 
flame atomic absorption spectrometer. The calibration 
curve for Fe standards (using ferrous ammonium sulfate) 
was linear in the range 0.5-10.0 /zg Fe. 
2.7. AI determination using aluminon 
A colorimetric assay for AI in solution was developed 
by an adaptation of the procedure used by Maloney et al. 
[23]. Equal volumes of 5 M ammonium chloride and 5 M 
ammonium acetate were mixed with 1/6 volume of 6 N 
HCI. This solution was 1:hen made 2% with aluminon 
(ammonium salt of aurin tricarboxylic acid), stirred and 
heated continuously to dissolve the aluminon, filtered while 
still warm through 1 MM Whatman paper, and centrifuged 
briefly prior to storage at 4°C. To measure A1, 12.5 /zl of 
this aluminon reagent was briefly heated to room tempera- 
ture, and mixed with 0.5 ml of Al-containing solution (pH 
6.0). After 1 h at room temperature, the A540 nm was 
determined. Corrections for protein content were made by 
carrying appropriate blanks with all incubations. The 
A540n m of AI solutions (made with Al-citrate) was linear in 
the range 0.02-20.0 /zg/rnl. 
2.8. Miscellaneous procedures 
Molecular weight determination by gel filtration chro- 
matography was performed as described by the manufac- 
turer. Protein concentration was determined according to 
the procedure of Lowry et al. [24] using bovine serum 
albumen as standard. Values for K d and Bma x were  calcu- 
lated by least squares linear regression of individual exper- 
imental data. Values in figures and tables are means _+ 
S.E.M. Values of P < 0.05 by Student's t-test are indi- 
cated with asterisks. 
3. Results 
3.1. Molecular weight of brain ferritin and PI protein 
fraction 
Brain ferritin preparations could be further separated by 
gel filtration on Sepharose 6B into an early protein frac- 
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Fig. 1. Gel filtration of brain ferritin preparation on Sepharose 6B. (A) 
Purified brain ferritin was subjected to additional gel filtration on 
Sepharose 6B (0.9 × 100 cm column). V b, elution volume of blue dextran; 
V t, total column volume. (B) M r determination f PI on Sepharose 6B. 
Fractions 20-25 (PI shown in A) were pooled, concentrated in an 
Amicon cell with a PM 50 membrane and re-applied to Sepharose 6B. 
The apparent M r was determined as described in Section 2. a: blue 
dextran (2.0 MDa), b: thyroglobulin (0.669 MDa), c: horse spleen ferritin 
(0.480 MDa), and d: catalase (0.248 MDa). All markers were applied to 
the column in a total volume of 1 ml, at a concentration f 2 mg/ml. 
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(Fig. IA). The M~ value for the PI fraction determined by 
gel filtration on Sepharose 6B was 2079000+ 101000 
(n = 4) (Fig. 1B). This value did not change significantly 
when Sepharose 4B, with a higher exclusion range, was 
used. Due to its high M r, PI did not migrate on non-dena- 
turing 3% polyacrylamide or 0.25% agarose gels so it was 
not possible to analyse its native components. Only two 
components were identified following centrifugation of PI 
for 27 h at 105000 × g in 0.5 M-3.0 M sucrose gradients 
(not shown). In liver, the PI fraction was absent from 
ferritin purified following heat and acid treatment and 
consisted only of ferritin (167 _+ 18.5 /zg ferritin/g wet 
weight; 0.14_+0.03 /zg of Fe//~g ferritin) and minor 
contaminants (not shown) eluting in the PII fraction. 
3.2. Elution profiles of PI and PII protein fraction from 
high speed pellet preparations 
Table 1 
Fe content and ferritin 
brain and liver 
immune reactivity of PI and PII fractions from 
Fraction Protein Iron Ferritin Iron/ferritin 
(mg/g wt.) ( ~g/mg ( #g/mg (/xg//zg) 
protein) protein) 
Brain PI 0.76+0.06 1.88+0.39 6.71 +0.31(4) 0.28+0.08 
BrainPII 0.13+0.01 * 2.43+0.73 1.64+0.29 *(4) 1.48+0.44" 
Liver PI 0.69+0.11 1.11+0.64 5.07+1.59(4) 0.22+0.05 
LiverPIl 1.51+0.21' 9.67-t-0.50' 7.22+0.40(4) 1.34+0.10 *
High speed pellets were obtained and ferritin activity of duplicate sam- 
ples was measured by immune assay with antibody against spleen ferritin, 
as described in Section 2. Fe was measured on duplicate samples by 
atomic absorbtion spectrometry at 248.3 nm after digestion with nitric 
acid. Values shown are means + S.E.M. of 3 determinations except where 
indicated in brackets. 
* P < 0.05 for PII compared to PI. 
Fig. 2 shows the distribution of ferritin epitopes and the 
absorbancy at 420 nm of column fractions eluted following 
Sepharose 6B gel filtration of the high speed pellets of rat 
brain. The major immune reactivity and absorbancy were 
in the high Mf proteins of the PI fraction. Much smaller 
values were observed in the low Mf proteins of the PII 
fraction. 
To determine if the PI fraction from brain contained 
aggregated ferritin, eluted fractions that were positive for 
ferritin were pooled and centrifuged at 160000 × g for 3.5 
h. The pellet was resuspended in a 0.1%(w/v) SDS solu- 
tion, applied to a Sepharose 6B column equilibrated with 
0.1% SDS in 20 mM Na2HPO 4 (pH 7.0), and the proteins 
eluted. Several peptides with a lower M r than those in the 
original PI fraction dissociated under these conditions. 
However, most of the radioactivity due to ferritin epitopes 
remained in the fraction containing the high M r proteins. 
Further attempts were made to disaggregate he proteins 
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Fig. 2. Gel filtration of brain proteins of the high speed pellet on 
Sepharose 6B. Fractions were collected for measurement of the A42 onm 
and the reactivity ospleen ferritin antiserum was measured asdescribed 
in Section 2. Markers as described for Fig. lB. 
in this fraction and the results were analyzed by gel 
electrophoresis. No disaggregation was found after incuba- 
tion with 9 M guanidinium chloride, 6 M urea, or ribo- 
nuclease A. In addition, removal of brain lipids from the 
homogenate with ethanol-ether prior to fractionation did 
not change the distribution of the proteins in the PI and PII 
fractions. 
3.3. Ferritin and Fe content in PI and PH fractions 
The absorbancy of ferritins at 420 nm is due to their Fe 
content [1,17]. Since PI fractions from both brain and liver 
had high 420 nm absorbancies, the Fe content in these 
fractions was measured by atomic absorption spectrometry. 
As shown in Table 1, in the brain, the level of Fe in the 
proteins of the PI fraction was similar to that in the PII 
fraction. However, in the liver, the Fe content of the 
proteins of the PI fraction was only about 10% of that of 
the proteins in the PII fraction. The reactivity to ferritin 
antiserum was four times higher in brain proteins of the PI 
fraction compared to those of the PII fraction. In liver, the 
immunoreactivity was similar for proteins of the PI and PII 
fractions. The ratio of Fe to fen-itin immunoreactivity was 
similar in the brain PI and in the liver PI fraction (0.28 
compared to 0.22). The ratio in the PII fraction was 5 
times higher and was similar in brain and liver (1.48 
compared to 1.34). The results suggest that similar 
ferritin-like, Fe-containing proteins are present in the PI 
fractions of both tissues. 
3.4. Fe and Al binding to brain PI fractions 
A Scatchard plot [25] of Fe binding to brain PI proteins 
(Fig. 3) revealed two classes of binding sites for Fe: site 1 
with a K s = 157 + 30 × 10 -6 M and Bma x = 1.42 + 0.15 
/xmol Fe /mg protein, and site 2 with a K d = 890 + I00 × 
10 -6 M and Bma x = 5.24 + 0.96 /xmol Fe /mg protein. 
Chelation of PI with 1% thioglycollic acid increased sig- 




° c ° o 
0 
0 1 2 3 4 5 
BOUND Fe 
( j=mot /ml  p ro t . )  
Fig. 3. Scatchard plot of Fe binding to the brain PI fraction before (O)  
and after (O)  chelation with 1% thioglycollate solution. The PI fraction 
(0.2 mg/ml  final concentratioa) was dialysed against 0.2 M sodium 
acetate (pH 6.0) containing Fe (as ferrous ammonium sulfate) ranging 
from 0.01 to 5.0 mM. Fe was removed by chelation with 1% thioglycollic 
acid in 0.1 M acetate buffer (pH 6.0), followed by extensive dialysis with 
0.05 M Tris-HCl (pH 8.5) containing 0.2 mM EDTA. Fe was measured 
by atomic absorption spectrometry. Means for 3 preparations, each 
determined in duplicate. 
nificantly the binding affinity for Fe at site 1 (K~ = 45.0 + 
7.0 X 10 -6  M;  P < 0.05) while total Fe binding at either 
site was unchanged (Fig. 3). In the case of PII protein 
fraction, a plot of the iniitial Fe concentration against he 
amount of Fe taken up per mg of protein, displayed a 
sigmoidal binding curve, as described previously for horse 
liver and spleen ferritin [126]. 
The Scatchard plot for A1 binding to PI proteins re- 
vealed only one site with a K d = 59.7 _ 13.6 × 10 -6  M 
and Bma x = 0.24_ 0.02 /zmol A1/mg protein (Fig. 4). 
Although the binding affinity for A1 to PI proteins was 
greater than that for Fe, the specific sites involved in Fe 
and A1 binding may or may not coincide. The Bma x for AI 
was one-sixth of that for Fe. 
3.5. Dissociation of bound metals from brain Pl fraction 
PI fraction proteins containing bound Fe or A1 were 
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Fig. 4. Scatchard plot of A1 binding to the brain PI fraction. Equilibrium 
dialysis of the PI protein fraction against Al-citrate (AI range: 0.01-0.25 
mM) was performed as described in Fig. 3. AI was measured colorimetri- 
cally from its reaction with aluminon, as described in Section 2. Means 
for 8 preparations, each determined in duplicate. 
M Tris-HC1 (pH 7.4) containing 0.2 mM EDTA, to distin- 
guish between loosely and tightly bound ions (Table 2). A 
significant amount of bound Fe was removed only in the 
presence of EDTA. In the case of A1, approx. 25% was 
loosely bound, and 40% of the remaining AI was removed 
when EDTA was included in the dialysis buffer. 
4. Discussion 
These results show that an MB protein elutes in a high 
molecular weight protein fraction (PI) from rat brain (ap- 
parent M r = 2.0 MDa). This protein, currently being fur- 
ther studied, was identified by its immune reactivity with 
antiserum to spleen ferritin, Fe content, and in vitro Fe and 
AI binding. Fe bound strongly to this fraction and could 
only be partially removed by chelation with EDTA, 
whereas A1 was mostly loosely bound and chelatable. 
Brain ferritin eluted with its characteristic M r of = 0.5 
MDa in the PII protein fraction, as determined by im- 
munoassay with antiserum to ferritin, and in vitro Fe 
uptake. 
Table 2 
Dissociation of Fe and AI from brain PI fraction following equilibrium dialysis 
Metal I II III 
Total bound Bound after dialysis Bound after dialysis + EDTA 
( /xmol /mg) (~mol /mg)  (% of Total) ( /zmol /mg) (% of Total) 
Fe 1.25 4-0.06 1.05 4-0.07 84 0.93 +0.11 * * 74 
AI 0.17 +_ 0.01 0.13 + 0.01 * 75 0.06 4- 0.01 * 34 
Approximately 1 mg of brain PI fraction was dialyzed against saturating concentrations of Fe (2.0 mM) or A1 (0.40 mM). Aliquots of the recovered protein 
solution were used to determine metal bound (I), or were dialyzed against 10 mM Tris-HC1 (pH 7.4) (II) or against 10 mM Tris-HC1 (pH 7.4) plus 0.2 mM 
EDTA (l id before metal analysis. Means _ S.E.M. of 4 preparations. 
P < 0.05 for II vs I or III w,; II. * * P < 0.05 for III vs I. 
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It is intriguing that ferritin immunoreactivity n the PI 
fraction had an apparent M r of 2.0 MDa, four times 
greater than that of the 24 subunit ferritin. One possibility 
is that the MB protein of this fraction is an unusual ferritin 
of about 96 subunits. For example, ferritins with more than 
34 subunits are expressed in cardiac and skeletal muscle 
[6] and the formation of ferritin oligomers has also been 
reported [7-9]. Alternatively, the MB protein may not be 
ferritin, but a different protein that shares common epi- 
topes with ferritin, possibly related to the metal-binding 
domain. This protein may elute together with other pro- 
teins, as part of a large molecular weight complex, which 
could explain the high apparent M r of this ferritin 
immunoreactivity. 
Our finding of a sizeable pool of a ferritin-im- 
munoreacting protein is supported by in situ immuno- 
staining experiments in which two large cell populations, 
namely microglia and oligodendrocytes, stained with fer- 
ritin antiserum. By contrast, neurons did not stain with 
fen'kin antiserum [27]. The antiserum used throughout this 
work was calibrated against HSF, which is composed 
primarily of L subunits [1]. When we studied rat brain 
homogenates with this antiserum, the amount of ferritin 
measured was 38.4 + 3.0 (n = 8) /zg/g wet weight, or 
approx. 0.40/zg/mg of protein. These values were similar 
to those reported for young rat brain, though not human 
brain, using similar antiserum [22,28] and for adult rat 
brain using purified ferritin assayed by the Lowry proce- 
dure [11]. Thus the antiserum likely recognizes both L and 
H chains. An accurate value for the ratio of L to H chains 
depends on the ability of antibody to distinguish the two 
isoforms independently and this has been difficult for 
rodent ferritin [28]. 
There are several noteworthy similarities between met- 
als binding to the PI fraction compared to HSF. Price and 
Joshi [3] found two binding sites for Zn and Cd on HSF, 
but only one for Cu, with affinities ranging from 1.56- 
44.1 X 10 -6 M. Following chelation with 1% thioglycollic 
acid solution, the binding affinities of Zn and Cu doubled 
[3]. In the present work, the K d for Fe binding to the high 
affinity site (site 1) on the PI MB protein was 157 + 30 × 
10 -6 M, and also increased following chelation (Fig. 3). 
Interestingly, the presence of 0.17 mM of AI in the binding 
experiments lowered the Bma x for Fe binding to thioglycol- 
lic acid-chelated PI protein, with little change in the bind- 
ing affinity for Fe at site 1 (not shown). A1 may induce a 
conformational change of the Fe binding site since low 
concentrations of A1 (range 0.0012-0.012 mM) reduced Fe 
loading of human brain ferritin [29]. The binding data for 
A1 revealed one site with K d -- 59.7 __+ 13.6 × 10 -6 M and 
Bma x = 0.24 + 0.02 /zmol Al /mg protein (Fig. 4). A K d 
of 45 × 10 -6 M was reported for AI binding to HSF [30]. 
In vitro protein synthesis increased upon exposure of 
infant rats to AI, as a result of increased polysomal trans- 
latability. Among the newly synthesized proteins the level 
of a protein reacting with antiserum to spleen ferritin was 
significantly increased as compared to unexposed controls 
[12]. In view of the reactivity of this antiserum with the 
MB proteins in the PI fraction, it now appears likely that 
one of the proteins whose synthesis was increased by AI 
exposure is the MB protein. Previous reports showed that 
AI may accumulate readily in rabbit brains, especially 
when administered as lipophilic Al-maltolate, triggering 
the onset of a progressive neuropathology in which the 
transcription of several mRNA's is impaired and elevated 
AI concentrations are found in the nucleus [13-15,31,32]. 
However, in the rat brain, A1 accumulates in the cytosol 
rather than in the nucleus but no pathology ensues [13]. It 
is possible that the decreased A1 neurotoxicity in rats may 
result from the presence of a cytosolic protein such as the 
MB protein which has been described here. In humans 
susceptible to A1 accumulation i the brain [33], decreases 
of an inducible MB protein, as well as ferritin [29], might 
predispose to neuropathology. 
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